Terms: = Ovarian cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Staging
3 results:
1. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract] [Full Text] [Related]
2. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Feb; 15(2):291-6. PubMed ID: 16391844
[TBL] [Abstract] [Full Text] [Related]
